Results
8460
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,460 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PHM | €98.40 | 2.6% | 198.7% | €1.7b | €91.00 | PE2753.7x | E45.4% | 0.7% | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.31 | 1.3% | 45.5% | ج.م28.3b | ج.م12.45 | PE22.9x | E27.4% | n/a | Diversified Financials | ||
AFISH | NOK 61.00 | -8.3% | 5.2% | NOK 1.9b | NOK 81.00 | PE63.8x | E55.2% | n/a | Food, Beverage & Tobacco | ||
MBTN | CHF 1.78 | -6.3% | -97.4% | CHF 54.9m | CHF 6.03 | PS0.6x | E109.3% | n/a | Semiconductors | ||
PRICOLLTD | ₹437.75 | -11.5% | 9.0% | ₹53.4b | ₹590.00 | PE30.7x | E25.2% | 0% | Automobiles | ||
JYOTICNC | ₹881.25 | -17.3% | 40.7% | ₹200.4b | ₹1,190.00 | PE65.4x | E29.4% | n/a | Capital Goods | ||
AGP | €6.52 | 26.1% | -18.9% | €118.9m | €12.40 | PE17.6x | E23.3% | n/a | Capital Goods | ||
MVW | NOK 10.00 | 1.0% | 20.5% | NOK 327.2m | NOK 11.70 | PS14.4x | E62.2% | n/a | Materials | ||
CADLR | NOK 52.00 | -4.2% | 18.2% | NOK 18.2b | NOK 81.13 | PE171.7x | E70.7% | n/a | Capital Goods | ||
RMDA | ج.م3.77 | 12.5% | 25.2% | ج.م5.7b | ج.م5.18 | PE21.3x | E30.7% | 1.8% | Pharmaceuticals & Biotech | ||
YGG | ฿0.66 | 8.2% | -90.4% | ฿397.3m | ฿10.75 | PS1.8x | E87.1% | 40.6% | Media | ||
NYKAA | ₹165.58 | -2.8% | 8.7% | ₹473.4b | ₹190.08 | PE898x | E43.8% | n/a | Retail | ||
GUINNESS | ₦74.00 | -3.9% | 45.1% | ₦162.1b | ₦74.24 | PS0.4x | E119.5% | 0% | Food, Beverage & Tobacco | ||
RHM | €889.60 | 17.5% | 121.5% | €38.6b | €862.93 | PE56.4x | E30.5% | 0.6% | Capital Goods | ||
PRL | CA$33.29 | -8.5% | 97.9% | CA$1.3b | CA$45.45 | PE21.1x | E38.7% | 1.8% | Diversified Financials | ||
ACE | SEK 3.29 | 7.0% | -55.7% | SEK 316.2m | SEK 7.68 | PB4x | E66.9% | n/a | Pharmaceuticals & Biotech | ||
ELABS | NOK 9.63 | 1.6% | -29.4% | NOK 1.0b | NOK 19.00 | PS10.8x | E121.1% | n/a | Software | ||
ICOP | €8.26 | 0% | n/a | €228.3m | €9.80 | PE45.2x | E49.2% | n/a | Capital Goods | ||
XSPRAY | SEK 31.45 | -9.2% | -22.9% | SEK 1.2b | SEK 55.50 | PB1.9x | E104.9% | n/a | Pharmaceuticals & Biotech | ||
SFPTECH | RM 0.41 | -33.6% | -56.5% | RM 972.0m | RM 0.96 | PE25.3x | E28.3% | 1.0% | Capital Goods | ||
ACI | ₹449.45 | -0.5% | -39.8% | ₹55.5b | ₹688.00 | PE33.4x | E50.1% | 0.7% | Materials | ||
DOMS | ₹2,576.20 | 1.7% | 69.0% | ₹156.3b | ₹3,009.29 | PE78.5x | E22.3% | 0.1% | Commercial Services | ||
ARES | US$179.69 | -2.5% | 34.1% | US$58.5b | US$198.57 | PE82.3x | E41.4% | 2.5% | Diversified Financials | ||
ALNY | US$251.00 | -5.2% | 54.2% | US$32.4b | US$301.27 | PS14.5x | E59.1% | n/a | Pharmaceuticals & Biotech |